Neurostimulation Market
Description
Neurostimulation Market
Neurostimulation is used for the treatment of various debilitating conditions such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression and essential tremors. Neurostimulation is a highly potential treatment option for patients who do not obtain relief from medications and surgical therapies. It improves the quality of life of patients who are severely paralyzed or suffering from intense loss of various sense organs. Therefore, neurostimulation is highly instrumental in artificial vision, hearing aids, artificial limbs and other prosthetics.
The global neurostimulation market is analyzed based on the therapies in which neurostimulation systems are utilized. This includes the following segments:
Deep brain stimulation (DBS)
Spinal cord stimulation (SCS)
Vagus nerve stimulation (VNS)
Sacral nerve stimulation (SNS)
Spinal cord stimulation therapy accounts for the largest share in the global neurostimulation market owing to the presence of a large number of SNS neurostimulators in treating diabetic neuropathy, pain, postherpetic neuralgia, ischemic limb pain and acute herpes zoster pain. Deep brain stimulators are currently approved for the treatment of neurological disorders such as Parkinson’s disease, epilepsy, dystonia, obsessive-compulsive disorder (OCD), essential tremors and depression. However, extensive research and advancement in technology leading to new, exciting applications such as stroke, obesity, autism, sleep disorders and many others will expand the deep brain stimulator market at a faster pace.
There is a rising need for devices with improved outcome, ability to pre-sense a neurological episode on-set, optimize the inter-device communication and better user interface. Developing technologies sufficing the treatment objective and market demand will lead to an increase in the demand for neurostimulation therapy and devices. Moreover, aging population driving rise in the incidence of neurological disorders such as Parkinson’s disease, epilepsy, essential tremors and depression related disorders will lead to an increase in demand for neurostimulation. In addition, neurostimulation devices and systems are gaining acceptance for the treatment of chronic pain especially in the developing economies such as India, China, Brazil, Mexico and Russia. Furthermore, increase in FDA approvals for novel neurostimulators with new applications, will expedite the growth of the global neurostimulation market in the near future. However, lack of a reliable measuring systems which can provide the expected outcome of neurostimulation therapies is a major challenge for manufacturers. High cost of the therapy is a deterring factor for the neurostimulation market, which can be subsided by gaining reimbursement for such devices.
The neurostimulation market, currently, is strong in North America and Europe, but is experiencing faster growth in Asia-Pacific region, mainly across China, Brazil and India. Growth in the Asia-Pacific region will be mainly driven by increase in patient awareness and acceptance of neurostimulation as an alternative treatment for chronic pain and neurological disorders. Neurostimulation device manufacturing companies and their research affiliates are continuously working on developing novel devices and technologies which can enhance the therapeutic outcome of existing devices and simultaneously gain market advantage. The strategic approaches followed by these companies are focusing on creating new markets and increasing their existing market share.
The global neurological market is characterized by few dominating players which pose a challenge for the new entrants in the global neurostimulation market. The major players in the neurostimulation market include Boston Scientific Corporation, Cyberonics Inc., St. Jude Medical Inc., Medtronic Inc., NeuroPace Inc., and NeuroSigma, Inc.
This research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product types and distribution channels.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Historical Actual Market Size, 2012 - 2014
Market Size & Forecast 2015 to 2025
Supply & Demand Value Chain
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Market Drivers and Restraints
Regional analysis includes
North America
US & Canada
Latin America
Brazil, Argentina & Others
Western Europe
EU5
Nordics
Benelux
Eastern Europe
Asia Pacific
Australia and New Zealand (ANZ)
Greater China
India
ASEAN
Rest of Asia Pacific
Japan
Middle East and Africa
GCC Countries
Other Middle East
North Africa
South Africa
Other Africa
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
Detailed overview of parent market
Changing market dynamics of the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
Must-have information for market players to sustain and enhance their market footprint
Neurostimulation is used for the treatment of various debilitating conditions such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression and essential tremors. Neurostimulation is a highly potential treatment option for patients who do not obtain relief from medications and surgical therapies. It improves the quality of life of patients who are severely paralyzed or suffering from intense loss of various sense organs. Therefore, neurostimulation is highly instrumental in artificial vision, hearing aids, artificial limbs and other prosthetics.
The global neurostimulation market is analyzed based on the therapies in which neurostimulation systems are utilized. This includes the following segments:
Deep brain stimulation (DBS)
Spinal cord stimulation (SCS)
Vagus nerve stimulation (VNS)
Sacral nerve stimulation (SNS)
Spinal cord stimulation therapy accounts for the largest share in the global neurostimulation market owing to the presence of a large number of SNS neurostimulators in treating diabetic neuropathy, pain, postherpetic neuralgia, ischemic limb pain and acute herpes zoster pain. Deep brain stimulators are currently approved for the treatment of neurological disorders such as Parkinson’s disease, epilepsy, dystonia, obsessive-compulsive disorder (OCD), essential tremors and depression. However, extensive research and advancement in technology leading to new, exciting applications such as stroke, obesity, autism, sleep disorders and many others will expand the deep brain stimulator market at a faster pace.
There is a rising need for devices with improved outcome, ability to pre-sense a neurological episode on-set, optimize the inter-device communication and better user interface. Developing technologies sufficing the treatment objective and market demand will lead to an increase in the demand for neurostimulation therapy and devices. Moreover, aging population driving rise in the incidence of neurological disorders such as Parkinson’s disease, epilepsy, essential tremors and depression related disorders will lead to an increase in demand for neurostimulation. In addition, neurostimulation devices and systems are gaining acceptance for the treatment of chronic pain especially in the developing economies such as India, China, Brazil, Mexico and Russia. Furthermore, increase in FDA approvals for novel neurostimulators with new applications, will expedite the growth of the global neurostimulation market in the near future. However, lack of a reliable measuring systems which can provide the expected outcome of neurostimulation therapies is a major challenge for manufacturers. High cost of the therapy is a deterring factor for the neurostimulation market, which can be subsided by gaining reimbursement for such devices.
The neurostimulation market, currently, is strong in North America and Europe, but is experiencing faster growth in Asia-Pacific region, mainly across China, Brazil and India. Growth in the Asia-Pacific region will be mainly driven by increase in patient awareness and acceptance of neurostimulation as an alternative treatment for chronic pain and neurological disorders. Neurostimulation device manufacturing companies and their research affiliates are continuously working on developing novel devices and technologies which can enhance the therapeutic outcome of existing devices and simultaneously gain market advantage. The strategic approaches followed by these companies are focusing on creating new markets and increasing their existing market share.
The global neurological market is characterized by few dominating players which pose a challenge for the new entrants in the global neurostimulation market. The major players in the neurostimulation market include Boston Scientific Corporation, Cyberonics Inc., St. Jude Medical Inc., Medtronic Inc., NeuroPace Inc., and NeuroSigma, Inc.
This research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product types and distribution channels.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Historical Actual Market Size, 2012 - 2014
Market Size & Forecast 2015 to 2025
Supply & Demand Value Chain
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Market Drivers and Restraints
Regional analysis includes
North America
US & Canada
Latin America
Brazil, Argentina & Others
Western Europe
EU5
Nordics
Benelux
Eastern Europe
Asia Pacific
Australia and New Zealand (ANZ)
Greater China
India
ASEAN
Rest of Asia Pacific
Japan
Middle East and Africa
GCC Countries
Other Middle East
North Africa
South Africa
Other Africa
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
Detailed overview of parent market
Changing market dynamics of the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
Must-have information for market players to sustain and enhance their market footprint
Table of Contents
250 Pages
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Product Life Cycle Analysis
- 3.5. Supply Chain Analysis
- 3.5.1. Supply Side Participants and their Roles
- 3.5.1.1. Producers
- 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
- 3.5.1.3. Wholesalers and Distributors
- 3.5.2. Value Added and Value Created at Node in the Supply Chain
- 3.5.3. List of Raw Material Suppliers
- 3.5.4. List of Existing and Potential Buyer’s
- 3.6. Investment Feasibility Matrix
- 3.7. Value Chain Analysis
- 3.7.1. Profit Margin Analysis
- 3.7.2. Wholesalers and Distributors
- 3.7.3. Retailers
- 3.8. PESTLE and Porter’s Analysis
- 3.9. Regulatory Landscape
- 3.9.1. By Key Regions
- 3.9.2. By Key Countries
- 3.10. Regional Parent Market Outlook
- 3.11. Production and Consumption Statistics
- 3.12. Import and Export Statistics
- 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product , 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product , 2022-2032
- 5.3.1. Internal Stimulation
- 5.3.2. External Stimulation
- 5.4. Y-o-Y Growth Trend Analysis By Product , 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Product , 2022-2032 Deep-dive segmentation will be available in the sample on request
- 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2022-2032
- 6.3.1. Pain Management
- 6.3.2. Epilepsy
- 6.3.3. Essential Tremor
- 6.3.4. Urinary & Fecal Incontinence
- 6.3.5. Dystonia
- 6.3.6. Gastroparesis
- 6.3.7. Parkinson's Disease
- 6.3.8. Others
- 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 Deep-dive segmentation will be available in the sample on request
- 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021
- 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032
- 7.3.1. Hospitals
- 7.3.2. Specialized Clinics
- 7.3.3. Ambulatory Surgical Centers
- 7.3.4. Home Care Settings
- 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
- 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032 Deep-dive segmentation will be available in the sample on request
- 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 8.1. Introduction
- 8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
- 8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
- 8.3.1. North America
- 8.3.2. Latin America
- 8.3.3. Europe
- 8.3.4. East Asia
- 8.3.5. South Asia & Pacific
- 8.3.6. MEA
- 8.4. Market Attractiveness Analysis By Region
- 9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 9.2.1. By Country
- 9.2.1.1. U.S.
- 9.2.1.2. Canada
- 9.2.2. By Product
- 9.2.3. By Application
- 9.2.4. By End User
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Product
- 9.3.3. By Application
- 9.3.4. By End User
- 9.4. Key Takeaways
- 10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. Mexico
- 10.2.1.2. Brazil
- 10.2.1.3. Rest of Latin America
- 10.2.2. By Product
- 10.2.3. By Application
- 10.2.4. By End User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By Application
- 10.3.4. By End User
- 10.4. Key Takeaways
- 11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. Germany
- 11.2.1.2. Italy
- 11.2.1.3. France
- 11.2.1.4. U.K.
- 11.2.1.5. Spain
- 11.2.1.6. BENELUX
- 11.2.1.7. Russia
- 11.2.1.8. Rest of Europe
- 11.2.2. By Product
- 11.2.3. By Application
- 11.2.4. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Product
- 11.3.3. By Application
- 11.3.4. By End User
- 11.4. Key Takeaways
- 12. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. China
- 12.2.1.2. Japan
- 12.2.1.3. South Korea
- 12.2.2. By Product
- 12.2.3. By Application
- 12.2.4. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Product
- 12.3.3. By Application
- 12.3.4. By End User
- 12.4. Key Takeaways
- 13. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. India
- 13.2.1.2. ASEAN
- 13.2.1.3. Australia and New Zealand
- 13.2.1.4. Rest of South Asia & Pacific
- 13.2.2. By Product
- 13.2.3. By Application
- 13.2.4. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Product
- 13.3.3. By Application
- 13.3.4. By End User
- 13.4. Key Takeaways
- 14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 14.2.1. By Country
- 14.2.1.1. GCC Countries
- 14.2.1.2. Turkey
- 14.2.1.3. South Africa
- 14.2.1.4. Rest of MEA
- 14.2.2. By Product
- 14.2.3. By Application
- 14.2.4. By End User
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Product
- 14.3.3. By Application
- 14.3.4. By End User
- 14.4. Key Takeaways
- 15. Key Countries Market Analysis
- 15.1. U.S.
- 15.1.1. Pricing Analysis
- 15.1.2. Market Share Analysis, 2021
- 15.1.2.1. By Product
- 15.1.2.2. By Application
- 15.1.2.3. By End User
- 15.2. Canada
- 15.2.1. Pricing Analysis
- 15.2.2. Market Share Analysis, 2021
- 15.2.2.1. By Product
- 15.2.2.2. By Application
- 15.2.2.3. By End User
- 15.3. Mexico
- 15.3.1. Pricing Analysis
- 15.3.2. Market Share Analysis, 2021
- 15.3.2.1. By Product
- 15.3.2.2. By Application
- 15.3.2.3. By End User
- 15.4. Brazil
- 15.4.1. Pricing Analysis
- 15.4.2. Market Share Analysis, 2021
- 15.4.2.1. By Product
- 15.4.2.2. By Application
- 15.4.2.3. By End User
- 15.5. Germany
- 15.5.1. Pricing Analysis
- 15.5.2. Market Share Analysis, 2021
- 15.5.2.1. By Product
- 15.5.2.2. By Application
- 15.5.2.3. By End User
- 15.6. Italy
- 15.6.1. Pricing Analysis
- 15.6.2. Market Share Analysis, 2021
- 15.6.2.1. By Product
- 15.6.2.2. By Application
- 15.6.2.3. By End User
- 15.7. France
- 15.7.1. Pricing Analysis
- 15.7.2. Market Share Analysis, 2021
- 15.7.2.1. By Product
- 15.7.2.2. By Application
- 15.7.2.3. By End User
- 15.8. U.K.
- 15.8.1. Pricing Analysis
- 15.8.2. Market Share Analysis, 2021
- 15.8.2.1. By Product
- 15.8.2.2. By Application
- 15.8.2.3. By End User
- 15.9. Spain
- 15.9.1. Pricing Analysis
- 15.9.2. Market Share Analysis, 2021
- 15.9.2.1. By Product
- 15.9.2.2. By Application
- 15.9.2.3. By End User
- 15.10. BENELUX
- 15.10.1. Pricing Analysis
- 15.10.2. Market Share Analysis, 2021
- 15.10.2.1. By Product
- 15.10.2.2. By Application
- 15.10.2.3. By End User
- 15.11. Russia
- 15.11.1. Pricing Analysis
- 15.11.2. Market Share Analysis, 2021
- 15.11.2.1. By Product
- 15.11.2.2. By Application
- 15.11.2.3. By End User
- 15.12. China
- 15.12.1. Pricing Analysis
- 15.12.2. Market Share Analysis, 2021
- 15.12.2.1. By Product
- 15.12.2.2. By Application
- 15.12.2.3. By End User
- 15.13. Japan
- 15.13.1. Pricing Analysis
- 15.13.2. Market Share Analysis, 2021
- 15.13.2.1. By Product
- 15.13.2.2. By Application
- 15.13.2.3. By End User
- 15.14. South Korea
- 15.14.1. Pricing Analysis
- 15.14.2. Market Share Analysis, 2021
- 15.14.2.1. By Product
- 15.14.2.2. By Application
- 15.14.2.3. By End User
- 15.15. India
- 15.15.1. Pricing Analysis
- 15.15.2. Market Share Analysis, 2021
- 15.15.2.1. By Product
- 15.15.2.2. By Application
- 15.15.2.3. By End User
- 15.16. ASEAN
- 15.16.1. Pricing Analysis
- 15.16.2. Market Share Analysis, 2021
- 15.16.2.1. By Product
- 15.16.2.2. By Application
- 15.16.2.3. By End User
- 15.17. Australia and New Zealand
- 15.17.1. Pricing Analysis
- 15.17.2. Market Share Analysis, 2021
- 15.17.2.1. By Product
- 15.17.2.2. By Application
- 15.17.2.3. By End User
- 15.18. GCC Countries
- 15.18.1. Pricing Analysis
- 15.18.2. Market Share Analysis, 2021
- 15.18.2.1. By Product
- 15.18.2.2. By Application
- 15.18.2.3. By End User
- 15.19. Turkey
- 15.19.1. Pricing Analysis
- 15.19.2. Market Share Analysis, 2021
- 15.19.2.1. By Product
- 15.19.2.2. By Application
- 15.19.2.3. By End User
- 15.20. South Africa
- 15.20.1. Pricing Analysis
- 15.20.2. Market Share Analysis, 2021
- 15.20.2.1. By Product
- 15.20.2.2. By Application
- 15.20.2.3. By End User
- 16. Market Structure Analysis
- 16.1. Competition Dashboard
- 16.2. Competition Benchmarking
- 16.3. Market Share Analysis of Top Players
- 16.3.1. By Regional
- 16.3.2. By Product
- 16.3.3. By Application
- 16.3.4. By End User
- 17. Competition Analysis
- 17.1. Competition Deep Dive
- 17.1.1. Aleva Neurotherapeutics SA
- 17.1.1.1. Overview
- 17.1.1.2. Product Portfolio
- 17.1.1.3. Profitability by Market Segments
- 17.1.1.4. Sales Footprint
- 17.1.1.5. Strategy Overview
- 17.1.1.5.1. Marketing Strategy
- 17.1.1.5.2. Product Strategy
- 17.1.1.5.3. Channel Strategy
- 17.1.2. St. Jude Medical Inc.
- 17.1.2.1. Overview
- 17.1.2.2. Product Portfolio
- 17.1.2.3. Profitability by Market Segments
- 17.1.2.4. Sales Footprint
- 17.1.2.5. Strategy Overview
- 17.1.2.5.1. Marketing Strategy
- 17.1.2.5.2. Product Strategy
- 17.1.2.5.3. Channel Strategy
- 17.1.3. Medtronic PLC
- 17.1.3.1. Overview
- 17.1.3.2. Product Portfolio
- 17.1.3.3. Profitability by Market Segments
- 17.1.3.4. Sales Footprint
- 17.1.3.5. Strategy Overview
- 17.1.3.5.1. Marketing Strategy
- 17.1.3.5.2. Product Strategy
- 17.1.3.5.3. Channel Strategy
- 17.1.4. Boston Scientific Corporation
- 17.1.4.1. Overview
- 17.1.4.2. Product Portfolio
- 17.1.4.3. Profitability by Market Segments
- 17.1.4.4. Sales Footprint
- 17.1.4.5. Strategy Overview
- 17.1.4.5.1. Marketing Strategy
- 17.1.4.5.2. Product Strategy
- 17.1.4.5.3. Channel Strategy
- 17.1.5. LivaNova PLC
- 17.1.5.1. Overview
- 17.1.5.2. Product Portfolio
- 17.1.5.3. Profitability by Market Segments
- 17.1.5.4. Sales Footprint
- 17.1.5.5. Strategy Overview
- 17.1.5.5.1. Marketing Strategy
- 17.1.5.5.2. Product Strategy
- 17.1.5.5.3. Channel Strategy
- 17.1.6. Cochlear Ltd.
- 17.1.6.1. Overview
- 17.1.6.2. Product Portfolio
- 17.1.6.3. Profitability by Market Segments
- 17.1.6.4. Sales Footprint
- 17.1.6.5. Strategy Overview
- 17.1.6.5.1. Marketing Strategy
- 17.1.6.5.2. Product Strategy
- 17.1.6.5.3. Channel Strategy
- 17.1.7. Neuropace Inc.
- 17.1.7.1. Overview
- 17.1.7.2. Product Portfolio
- 17.1.7.3. Profitability by Market Segments
- 17.1.7.4. Sales Footprint
- 17.1.7.5. Strategy Overview
- 17.1.7.5.1. Marketing Strategy
- 17.1.7.5.2. Product Strategy
- 17.1.7.5.3. Channel Strategy
- 17.1.8. Neurosigma Inc.
- 17.1.8.1. Overview
- 17.1.8.2. Product Portfolio
- 17.1.8.3. Profitability by Market Segments
- 17.1.8.4. Sales Footprint
- 17.1.8.5. Strategy Overview
- 17.1.8.5.1. Marketing Strategy
- 17.1.8.5.2. Product Strategy
- 17.1.8.5.3. Channel Strategy
- 17.1.9. MED-EL GmbH
- 17.1.9.1. Overview
- 17.1.9.2. Product Portfolio
- 17.1.9.3. Profitability by Market Segments
- 17.1.9.4. Sales Footprint
- 17.1.9.5. Strategy Overview
- 17.1.9.5.1. Marketing Strategy
- 17.1.9.5.2. Product Strategy
- 17.1.9.5.3. Channel Strategy
- 17.1.10. Synapse Biomedical Inc.
- 17.1.10.1. Overview
- 17.1.10.2. Product Portfolio
- 17.1.10.3. Profitability by Market Segments
- 17.1.10.4. Sales Footprint
- 17.1.10.5. Strategy Overview
- 17.1.10.5.1. Marketing Strategy
- 17.1.10.5.2. Product Strategy
- 17.1.10.5.3. Channel Strategy
- 17.1.11. NDI Medical LLC
- 17.1.11.1. Overview
- 17.1.11.2. Product Portfolio
- 17.1.11.3. Profitability by Market Segments
- 17.1.11.4. Sales Footprint
- 17.1.11.5. Strategy Overview
- 17.1.11.5.1. Marketing Strategy
- 17.1.11.5.2. Product Strategy
- 17.1.11.5.3. Channel Strategy
- 17.1.12. EnteroMedics Inc.
- 17.1.12.1. Overview
- 17.1.12.2. Product Portfolio
- 17.1.12.3. Profitability by Market Segments
- 17.1.12.4. Sales Footprint
- 17.1.12.5. Strategy Overview
- 17.1.12.5.1. Marketing Strategy
- 17.1.12.5.2. Product Strategy
- 17.1.12.5.3. Channel Strategy
- 17.1.13. ImThera Medical
- 17.1.13.1. Overview
- 17.1.13.2. Product Portfolio
- 17.1.13.3. Profitability by Market Segments
- 17.1.13.4. Sales Footprint
- 17.1.13.5. Strategy Overview
- 17.1.13.5.1. Marketing Strategy
- 17.1.13.5.2. Product Strategy
- 17.1.13.5.3. Channel Strategy
- 18. Assumptions & Acronyms Used
- 19. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
